Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samsung Biologics | Seoul | Healthcare | Pharmaceuticals | ₩77.08T | 72.3x | 2.75 | ₩1,068,000 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩39.33T | 193.1x | -2.75 | ₩183,400 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
Alteogen | KOSDAQ | Healthcare | Pharmaceuticals | ₩19.83T | -4,279.7x | 42.3 | ₩370,000 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩10.46T | -47x | 0.78 | ₩78,500 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩9.02T | 60.5x | 0.57 | ₩106,000 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩9.02T | 60.5x | 0.57 | ₩119,900 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17% Upside | Upgrade to Pro+ | |
Sk Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩8.4T | 144.5x | 0.86 | ₩105,100 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.8% Upside | Upgrade to Pro+ | |
Sam Chun Dang Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩4.52T | 663.7x | 6.68 | ₩194,000 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Classys Inc | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩3.95T | 43.8x | -12.5 | ₩59,700 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.1% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.88T | -1,200.5x | -13.39 | ₩105,700 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.5% Upside | Upgrade to Pro+ | |
Hugel | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.55T | 28.3x | 0.62 | ₩329,000 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.1% Upside | Upgrade to Pro+ | |
Pharma Reaserch Products | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.29T | 30.4x | 1.4 | ₩318,500 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.1% Downside | Upgrade to Pro+ | |
SK Bioscience Co | Seoul | Healthcare | Pharmaceuticals | ₩3.26T | -101.7x | 0.38 | ₩40,650 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.26T | ₩42,000 | 5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Hanmi Pharm Co | Seoul | Healthcare | Pharmaceuticals | ₩3.16T | -12.3 | ₩244,000 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.3% Upside | Upgrade to Pro+ | ||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.55T | -35.3x | 9.45 | ₩142,200 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celltrion Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩2.29T | 95.3x | ₩52,700 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.09T | -108.9x | 15.24 | ₩87,200 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.91T | -29.4x | 0.07 | ₩39,550 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | |
Hanmi Science | Seoul | Healthcare | Pharmaceuticals | ₩1.89T | 19.3x | 9.56 | ₩27,300 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hanall Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.8T | -272.1x | 1.39 | ₩34,700 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.5% Upside | Upgrade to Pro+ | |
Lunit | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩1.54T | 0.18 | ₩52,400 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.4% Upside | Upgrade to Pro+ | ||
ST Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.52T | 49.5x | 0.27 | ₩73,300 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GC Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.46T | -102.5x | 0.07 | ₩125,800 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daewoong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.42T | 13.1x | 0.11 | ₩120,900 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Caregen | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.25T | 33.4x | -8.19 | ₩25,500 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.3% Upside | Upgrade to Pro+ | |
SD Biosensor | Seoul | Healthcare | Healthcare Equipment & Supplies | ₩1.21T | -21.9x | -0.21 | ₩9,910 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oscotec | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.19T | -226.6x | -3.4 | ₩32,350 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB Life Science | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.18T | 14.6x | 0.09 | ₩9,730 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.13T | 37.6x | 0.03 | ₩24,400 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nature Cell | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.05T | -258.4x | 0.28 | ₩15,980 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chong Kun Dang Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.04T | 6.4x | 0.14 | ₩77,800 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HK Inno.N | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.02T | 25.6x | ₩36,000 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Mezzion Pharma | KOSDAQ | Healthcare | Pharmaceuticals | ₩858.45B | -68.1x | -1.32 | ₩28,550 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩847.29B | -13.2x | 1.72 | ₩44,100 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boryung Pharm | Seoul | Healthcare | Pharmaceuticals | ₩825.36B | 10.6x | 0.11 | ₩9,680 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medy-Tox | KOSDAQ | Healthcare | Pharmaceuticals | ₩802.46B | 78.8x | 4.96 | ₩123,400 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daewoong | Seoul | Healthcare | Pharmaceuticals | ₩798.19B | 6.8x | 2.78 | ₩19,230 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.4% Upside | Upgrade to Pro+ | |
HLB Therapeutics | KOSDAQ | Healthcare | Pharmaceuticals | ₩737.25B | -31.2x | 0.06 | ₩8,680 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩707.55B | ₩15,970 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Chabiotech | KOSDAQ | Healthcare | Healthcare Providers & Services | ₩694.07B | -57.7x | -4.39 | ₩11,960 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dongkook Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | ₩685.03B | 11.3x | 0.38 | ₩15,310 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.6% Upside | Upgrade to Pro+ | |
T And L | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩645.76B | 15.4x | 0.5 | ₩77,600 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Green Cross Holdings | Seoul | Healthcare | Pharmaceuticals | ₩635.41B | -9.8x | 0.01 | ₩22,500 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross | Seoul | Healthcare | Pharmaceuticals | ₩635.41B | -9.8x | 0.01 | ₩13,750 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Donga Socio Holdings | Seoul | Healthcare | Pharmaceuticals | ₩625.7B | 11x | 0.21 | ₩101,200 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.9% Upside | Upgrade to Pro+ | |
Pharmicell | Seoul | Healthcare | Pharmaceuticals | ₩616.24B | -11.6x | ₩11,270 | 9.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Won Tech Co | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩594.09B | 15.8x | -11.81 | ₩6,590 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.8% Downside | Upgrade to Pro+ | |
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | ₩550.23B | 20.6x | -0.11 | ₩28,350 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | ₩550.23B | 20.6x | -0.11 | ₩60,500 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |